Patents by Inventor Mathieu Lazerges

Mathieu Lazerges has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11713481
    Abstract: A process for pre-concentration and detection of at least one single-stranded nucleic acid target molecule, the process comprising the steps of generating a flow of liquid comprising at least one magnetic nanoparticle in a micro-channel and a plurality of single-stranded nucleic acid probe molecules attached to the nanoparticle, generating an alternating magnetic field in the part of the micro-channel using an electromagnet, the magnetic field having an intensity and frequency that are suitable for causing magnetic hyperthermia of the nanoparticles so as to cause denaturing of the duplex formed by the single-stranded nucleic acid target molecule and the single-stranded nucleic acid probe molecule, and detecting the single-stranded target molecule dispersed in the liquid.
    Type: Grant
    Filed: October 5, 2018
    Date of Patent: August 1, 2023
    Assignees: Centre National de la Recherche Scientifique (CNRS), Institut National de La Sante et de la Recherche Medicale (INSERM), Sorbonne Universite
    Inventors: Marie-Charlotte Horny, Jean-Michel Siaugue, Vincent Dupuis, Mathieu Lazerges, Jean Gamby
  • Publication number: 20200263241
    Abstract: The invention relates to a process for pre-concentration and detection of at least one single-stranded nucleic acid target molecule, the process comprising steps of generating a flow of liquid comprising at least one magnetic nanoparticle in a micro-channel and a plurality of single-stranded nucleic acid probe molecules attached to the nanoparticle, of generating an alternating magnetic field in the part of the micro-channel by means of the electromagnet, the magnetic field having an intensity and frequency that are suitable for causing magnetic hyperthermia of the nanoparticles so as to cause denaturing of the duplex formed by the single-stranded nucleic acid target molecule and the single-stranded nucleic acid probe molecule, and detection of the single-stranded target molecule dispersed in the liquid.
    Type: Application
    Filed: October 5, 2018
    Publication date: August 20, 2020
    Inventors: Marie-Charlotte Horny, Jean-Michel Siaugue, Vincent Dupuis, Mathieu Lazerges, Jean Gamby
  • Publication number: 20150105426
    Abstract: The invention relates to novel formulations for topical local anaesthesia and for the use thereof as analgesics, antalgics, or as sexual retardants.
    Type: Application
    Filed: December 4, 2012
    Publication date: April 16, 2015
    Applicant: UNIVERSITE PARIS DESCARTES
    Inventors: Mathieu Lazerges, Philippe Espeau, Sylvie Sophie Crauste-Manciet, Denis Brossard, Yohann Corvis, Florence Agnely, Nicolas Huang